Cortical Metrics in Intervention Trials With Autism Spectrum Disorders
Status:
Withdrawn
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The investigators overarching aim is to obtain preliminary data to support a larger grant to
validate a novel objective, physiologically-based outcome measure for clinical trials in
autism spectrum disorders (ASDs) called the cortical metric. Absence of such an outcome
measure has greatly hindered the development of treatments for core symptoms of ASD.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Duke University
Collaborator:
North Carolina Translational and Clinical Sciences Institute